Additionally, a study comparing MEK1/2 levels between tumor and healthy HCC cells, found that only tumor cells showed high phosphorylated MEK1/2 levels and that an increased expression of MEK1 in HCC tumor cells lead to more growth in vivo and resistance to apoptosis in response to MEK inhibitor U0126 [252]. This evidence concerns the gene MAP2K1 and neoplasm.